Conformation analyses, dynamic behavior and amide bond distortions of medium-sized heterocycles. 1. Partially and fully reduced 1-benzazepines

Journal of Organic Chemistry

Volumn 70, Issue 5, 2005, Pages 1545-1551

  Qadir, Maryiam ^a   Cobb, Jonathan ^a   Sheldrake, Peter W ^b,e   Whittall, Neil ^b   White, Andrew J P ^c   King, Kuok Hii ^c   Horton, Peter N ^d   Hursthouse, Michael B ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL BONDS; CONFORMATIONS; GROUND STATE; NUCLEAR MAGNETIC RESONANCE; TRANSITION METALS; X RAY CRYSTALLOGRAPHY;

AMIDE BONDS; CONFORMATIONAL CHANGES; GROUND-STATE STRUCTURES; UNSATURATION;

ORGANIC COMPOUNDS;

1 BENZOYL 2,3,4,5 TETRAHYDRO 1H 1 BENZAZEPINE; 1 BENZOYL 2,5 DIHYDRO 1H 1 BENZAZEPINE; 1 BENZOYL 5 METHYL 2,3,4,5 TETRAHYDRO 1H 1 BENZAZEPINE; 1 BENZOYL 5 METHYLENE 2,3,4,5 TETRAHYDRO 1H BENZAZEPINE; 1 BENZYL 5 METHYL 2,3,4,5 TETRAHYDRO 1H 1 BENZAZEPINE; BENZAZEPINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ARYLATION; CATALYSIS; CHEMICAL BOND; CONFORMATIONAL TRANSITION; MATHEMATICAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLID; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

AMIDES; BENZAZEPINES; CRYSTALLOGRAPHY, X-RAY; CYCLIZATION; HETEROCYCLIC COMPOUNDS, 2-RING; MODELS, CHEMICAL; MOLECULAR CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 14544281506     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo048118b     Document Type: Article

References (19)

1. Kondo, K.; Ogawa, H.; Shinohara, T.; Kurimura, M.; Tanada, Y.; Kan, K.; Yamashita, H.; Nakamura, S.; Hirano, T.; Yamamura, Y.; Mori, T.; Tominaga, M.; Itai, A. J. Med. Chem. 2000, 43, 4388-4397.
2. Matsuhisa, A.; Kikuchi, K.; Sakamoto, K.; Yatsu, T.; Tanaka, A. Chem. Pharm. Bull. 1999, 47, 329-339.
3. (a) Kondo, K.; Kan, K.; Tanada, Y.; Bando, M.; Shinohara, T.; Kurimura, M.; Ogawa, H.; Nakamura, S.; Hirano, T.; Yamamura, Y.; Kido, M.; Mori, T.; Tominaga, M. J. Med. Chem. 2002, 45, 3805-3808.
4. (b) Kondo, K.; Ogawa, H.; Yamashita, H.; Miyamoto, H.; Tanaka, M.; Nakaya, K.; Kitano, K.; Yamamura, Y.; Nakamura, S.; Onogawa, T.; Mori, T.; Tominaga, M. Bioorg. Med. Chem. 1999, 7, 1743-1754.
5. (c) Kondo, K. Expert Opin. Ther. Pat. 2002, 12, 1249-1258.
6. Boger, D. L.; Turnbull, P. J. Org. Chem. 1997, 62, 5849-5863.
7. Qadir, M.; Priestley, R. E.; Rising, T. W. D. F.; Gelbrich, T.; Coles, S. J.; Hursthouse, M. B.; Sheldrake, P. W.; Whittall, N.; Hii, K. K. Tetrahedron Lett. 2003, 44, 3675-3678.
8. Caddick, S.; Kofie, W. Tetrahedron Lett. 2002, 43, 9347-9350.
9. The identity of compound 5 was verified via an independent synthesis; see Part 2 (the following paper).
10. Deiters, A.; Martin, S. F. Chem. Rev. 2004, 104, 2199-2238.
11. Hassner, A.; Amit, B. Tetrahedron Lett. 1977, 18, 3023-3026.
12. Hassner, A.; Amit, B.; Marks, V.; Gottlieb, H. E. J. Org. Chem. 2003, 68, 6853-6858.
13. -1 and negligible entropic contribution to the process (see Supporting Information).
14. -1.
15. Winkler, F. K.; Dunitz, J. D. J. Mol. Biol. 1971, 59, 169-182.
16. (a) Ohwada, T.; Achiwa, T.; Okamoto, I.; Shudo, K. Tetrahedron Lett. 1998, 39, 865-868.
17. (b) Otani, Y.; Nagae, O.; Naruse, Y.; Inagaki, S.; Ohno, M.; Yamaguchi, K.; Yamamoto, G.; Uchiyama, M.; Ohwada, T. J. Am. Chem. Soc. 2003, 125, 15191-15199.
18. Padwa, A.; Austin, D. J.; Price, A. T.; Weingarten, M. D. Tetrahedron 1996, 52, 3247-3260.
19. Ikeda, M.; Ohno, K.; Takahashi, M.; Uno, T.; Tamura, Y. J. Chem. Soc., Perkin Trans. 1 1982, 741-748.